tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability
PremiumRatingsCautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability
2M ago
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
Premium
The Fly
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
2M ago
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
Premium
The Fly
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
2M ago
Bolt Biotherapeutics initiated with a Buy at Lake Street
PremiumThe FlyBolt Biotherapeutics initiated with a Buy at Lake Street
5M ago
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
Premium
Ratings
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
5M ago
Cautious Hold Rating on Bolt Biotherapeutics Amid Promising Clinical Data and Financial Uncertainty
Premium
Ratings
Cautious Hold Rating on Bolt Biotherapeutics Amid Promising Clinical Data and Financial Uncertainty
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Bolt Biotherapeutics to host KOL call on BDC-3042 Phase 1 results
Premium
The Fly
Bolt Biotherapeutics to host KOL call on BDC-3042 Phase 1 results
6M ago
Bolt Biotherapeutics announces results for Boltbody ISACs at AACR meeting
Premium
The Fly
Bolt Biotherapeutics announces results for Boltbody ISACs at AACR meeting
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100